COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 3: Articles 21-30  | Next

Mitigation of imprinted antibody responses in elderly COVID-19 highly vaccinated individuals
Morse, R. B., Egan, D. J. S., Cheng, M. T. K., Altaf, M., Kamelian, K., Ceron-Gutierrez, L., Sokolova, O., Bradley, J., Smith, K. G. C., Doffinger, R., Tan, C. W., Gupta, R. K.
10.64898/2026.05.21.725708 — Posted: 2026-05-22
Force-regulated catch bonds and fusion peptide exposure drive coronavirus entry
Li, H., Li, Z., Gao, H.
10.64898/2026.05.21.727024 — Posted: 2026-05-22
Antioxidant properties of Rhodiola rosea
Brink, D. F., Sapp, T. L., Ghafoor, T. S., Boyland, P. A., Tamazawa, Y. C., Kaur, G., Shults, N. V., Sullivan, R. D., Suzuki, Y. J.
10.64898/2026.05.21.726678 — Posted: 2026-05-22
Spike antibodies targeting GRP78 predispose to cardiovascular complications compared to Dengue
Sarker, S., Roy, T., Mallick, A., Das, S., Teja, S. D., Bandyopadhyay, A., Gorai, S., De, A., Biswas, S.
10.64898/2026.05.20.726568 — Posted: 2026-05-21
Ribophorin-1 Governs Spike Abundance of Highly Pathogenic Coronaviruses by ER-associated degradation
Huang, Y.-J., Lv, L., Ran, W., Zhao, H., Deng, Y.-Q., Ye, Q., Li, L., Wu, X.-Y., Chen, Q., Hu, Y., Sun, B., Zhao, J.-J., Zhao, J., Qin, C.
10.64898/2026.05.20.726704 — Posted: 2026-05-21
Occupational hierarchy, racialization, and COVID-19 health outcomes among meat processing plant workers in Alberta: a community-engaged mixed-methods study
Essar, M. Y., Norrie, E., Cerino, E. R., Antonio, M., Saad, A., Yemane, M., Holdbrook, L., Sahilie, A., Youssef, M., Hassan, N., Magwood, O., Edwards, S. T., Spitzer, D., Coakley, A., Pottie, K., Fabreau, G. E.
10.64898/2026.05.14.26353257 — Posted: 2026-05-20
Exploring the genetic architecture of multimorbidity and its impact on long COVID risk
Bauer, S. J. M., Bowyer, R. C. E., Bravo Merodio, L., Gkoutos, G., Vetrano, D., Jackson, T., Freidin, M. B., Steves, C. J.
10.64898/2026.05.18.26353402 — Posted: 2026-05-20
The Potential Clinical and Economic Impact of a Combination COVID-19 and Influenza Vaccine (mRNA-1083) in Canada
Fust, K., Kohli, M., Cartier, S., Van de Velde, N., Mehta, D., Blake, M.
10.64898/2026.05.18.26353482 — Posted: 2026-05-20
Mechanochemical Decoupling of ATP Hydrolysis and RNA Translocation in SARS-CoV-2 nsp13 by the L405D Mutation
Fazelpour, E., Roy, P., Frederick, K., McCullagh, M.
10.64898/2026.05.18.726016 — Posted: 2026-05-20
Direct serological antibody discovery by integrative proteomics yields potent neutralizers overlooked by single-cell BCR sequencing
Tamara, S., van Rijswijck, D. M. H., van Rijswijk, J., Burger, J. A., Schulte, D., Moreschini, M., de Bree, G. J., van Gils, M. J., Heck, A. J. R., den Boer, M. A.
10.64898/2026.05.20.725438 — Posted: 2026-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).